RAPAFLO - silodosin
Navigation: NDC > Supplier starting with: W > WATSON PHARMA, INC.| Field | Value |
|---|---|
| NDC Code: | 52544-152 |
| Proprietary Name: | RAPAFLO |
| Suffix: | |
| Non-Proprietary Name: | silodosin |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 23-03-2009 |
| Category Name: | NDA |
| Application Number: | NDA022206 |
| Labeler: | WATSON PHARMA, INC. |
| Substance Name: | SILODOSIN |
| Active Numerator Strength: | 8 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| DEA Schedule: |